2005
DOI: 10.1186/1744-8069-1-32
|View full text |Cite
|
Sign up to set email alerts
|

Single Subject Pharmacological-MRI (phMRI) Study: Modulation of Brain Activity of Psoriatic Arthritis Pain by Cyclooxygenase-2 Inhibitor

Abstract: We use fMRI to examine brain activity for pain elicited by palpating joints in a single patient suffering from psoriatic arthritis. Changes in these responses are documented when the patient ingested a single dose of a selective cyclooxygenase-2 inhibitor (COX-2i). We show that mechanical stimulation of the painful joints exhibited a cortical activity pattern similar to that reported for acute pain, with activity primarily localized to the thalamus, insular, primary and secondary somatosensory cortices and the… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
16
0

Year Published

2007
2007
2015
2015

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 28 publications
(17 citation statements)
references
References 31 publications
(38 reference statements)
1
16
0
Order By: Relevance
“…These results, together with our fMRI studies in other chronic pain conditions (Baliki et al, 2008; Baliki et al, 2005; Farmer et al, 2011; Geha et al, 2007; Geha, Baliki, Wang, et al, 2008) and our additional brain morphometry studies (Baliki, Schnitzer, et al, 2011; Geha, Baliki, Harden, et al, 2008), have prompted the proposal of a new mechanistic model for the transition to pain chronicity. This model was proposed and expounded in three review articles (Apkarian, 2008; Apkarian et al, 2009; Apkarian et al, 2011).…”
Section: Overview Of Hints Of Mechanisms For the Transition From Acutmentioning
confidence: 79%
“…These results, together with our fMRI studies in other chronic pain conditions (Baliki et al, 2008; Baliki et al, 2005; Farmer et al, 2011; Geha et al, 2007; Geha, Baliki, Wang, et al, 2008) and our additional brain morphometry studies (Baliki, Schnitzer, et al, 2011; Geha, Baliki, Harden, et al, 2008), have prompted the proposal of a new mechanistic model for the transition to pain chronicity. This model was proposed and expounded in three review articles (Apkarian, 2008; Apkarian et al, 2009; Apkarian et al, 2011).…”
Section: Overview Of Hints Of Mechanisms For the Transition From Acutmentioning
confidence: 79%
“…The evoked pain results in similar brain activation as the acute pain in healthy controls. [43][44][45] Tonic clinical pain results in a different brain activity pattern than evoked clinical pain; for example, dynamic mechanical allodynia in patients with post-herpetic neuralgia results in different activation patterns than the ongoing pain. 43,46 Also the evoked pain differs from the ongoing, tonic pain in patients with arthritis.…”
Section: Evoked Versus Spontaneous Pain In Chronic Pain Patientsmentioning
confidence: 99%
“…A patient with chronic psoriatic pain was studied for brain activity regarding joint pain before and after oral administration of a cyclooxygenase-2 (COX-2) inhibitor [34]. The patient refrained from using his COX-2 inhibitor for 24 hours before participating in the study.…”
Section: Pharmacologic Fmri Of Painmentioning
confidence: 99%